Literature DB >> 9700671

Cerebrolysin protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia.

B Hutter-Paier1, E Steiner, M Windisch.   

Abstract

A brief period of histotoxic hypoxia exhibits certain metabolic features resembling the in vivo situation of ischemia. In this study the neuroprotective effects of the peptidergic nootropic drug Cerebrolysin (Cere) against iodoacetate induced histotoxic hypoxia were investigated. For that purpose isolated cortical neurons from 9 day chicken embryos were precultured with 0 to 6.4 mg.Cere/ml medium. At the 8th day in vitro histotoxic hypoxia was induced by incubation with 0.01 or 0.1 mM iodoacetate. Cells were allowed to recover from toxic stress for 3, 6, 24 or 48 hours. Cere protected neurons dose dependently from delayed neuronal cell death due to 0.01 mM iodoacetate even after a recovery period of 48h. After induction of histotoxic hypoxia by 0.1 mM iodoacetate high concentrations of Cere again led to neuronal protection after the 3 and 6 h recovery period. Moreover the influence of Cere on the cytoskeletal protein MAP2 in neurons submitted to 0.01 mM iodoacetate was investigated. With Western blotting and immunohistochemical techniques it has been demonstrated that the drug clearly increased MAP2 abundance after histotoxic hypoxia. The present study points out that after severe damage of cortical neurons with iodoacetate Cere is able to protect neurons from delayed neuronal cell death maybe by maintaining neuronal plasticity due to avoidance of the cytoskeletal breakdown.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700671     DOI: 10.1007/978-3-7091-6467-9_31

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  9 in total

1.  N-PEP-12--a novel peptide compound that protects cortical neurons in culture against different age and disease associated lesions.

Authors:  M Windisch; B Hutter-Paier; E Grygar; E Doppler; H Moessler
Journal:  J Neural Transm (Vienna)       Date:  2005-03-07       Impact factor: 3.575

2.  Neuroprotection of cerebrolysin in tissue culture models of brain ischemia: post lesion application indicates a wide therapeutic window.

Authors:  E Schauer; R Wronski; J Patockova; H Moessler; E Doppler; B Hutter-Paier; M Windisch
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

3.  A peptide preparation protects cells in organotypic brain slices against cell death after glutamate intoxication.

Authors:  C Riley; B Hutter-Paier; M Windisch; E Doppler; H Moessler; R Wronski
Journal:  J Neural Transm (Vienna)       Date:  2005-04-22       Impact factor: 3.575

4.  Reinnervation of the rat musculocutaneous nerve stump after its direct reconnection with the C5 spinal cord segment by the nerve graft following avulsion of the ventral spinal roots: a comparison of intrathecal administration of brain-derived neurotrophic factor and Cerebrolysin.

Authors:  P Haninec; P Dubový; F Sámal; L Houstava; L Stejskal
Journal:  Exp Brain Res       Date:  2004-09-04       Impact factor: 1.972

5.  Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate-severe traumatic brain injury.

Authors:  X Antón Alvarez; Carolina Sampedro; Jesús Figueroa; Iván Tellado; Andrés González; Manuel García-Fantini; Ramón Cacabelos; Dafin Muresanu; Herbert Moessler
Journal:  J Neural Transm (Vienna)       Date:  2008-02-14       Impact factor: 3.575

6.  Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndrome.

Authors:  Edith Doppler; Edward Rockenstein; Kiren Ubhi; Chandra Inglis; Michael Mante; Anthony Adame; Leslie Crews; Monika Hitzl; Herbert Moessler; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2008-07-04       Impact factor: 17.088

7.  Ciliary neurotrophic factor promotes motor reinnervation of the musculocutaneous nerve in an experimental model of end-to-side neurorrhaphy.

Authors:  Petr Dubový; Otakar Raška; Ilona Klusáková; Lubomír Stejskal; Pavel Celakovský; Pavel Haninec
Journal:  BMC Neurosci       Date:  2011-06-22       Impact factor: 3.288

8.  Cerebrolysin improves sciatic nerve dysfunction in a mouse model of diabetic peripheral neuropathy.

Authors:  Han-Yu Dong; Xin-Mei Jiang; Chun-Bo Niu; Lin Du; Jun-Yan Feng; Fei-Yong Jia
Journal:  Neural Regen Res       Date:  2016-01       Impact factor: 5.135

9.  Cerebrolysin administration reduces oxidative stress-induced apoptosis in lymphocytes from healthy individuals.

Authors:  Patrizia Formichi; Elena Radi; Carla Battisti; Giuseppe Di Maio; Dafin Muresanu; Antonio Federico
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.